AMGN Competitors & Alternatives
Compare Amgen Inc with similar stocks in the same industry
Drug Manufacturers - General
AMGN
Main Stock$360.45
Tradestie Score
56
Market Cap
$160.70B
P/E Ratio
25.3
Revenue Growth
0.1%
Analyst Upside
-1.3%
Top Competitors
16 stocks in Drug Manufacturers - General| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NVO
Novo-Nordisk A/S
|
$49.28
|
$262.92B | 11.9 | 64 | Compare |
|
AZN
AstraZeneca PLC
|
$169.47
|
$261.56B | 25.8 | 51 | Compare |
|
NVS
Novartis AG
|
$153.37
|
$254.99B | 22.1 | 49 | Compare |
|
MRK
Merck & Co., Inc.
|
$124.03
|
$225.13B | 34.8 | 59 | Compare |
|
PFE
Pfizer Inc.
|
$24.48
|
$154.70B | 18.5 | 56 | Compare |
|
GILD
Gilead Sciences Inc
|
$131.40
|
$137.92B | 17.7 | 64 | Compare |
|
SNY
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
|
$44.00
|
$121.27B | 19.3 | 64 | Compare |
|
BMY
Bristol-Myers Squibb Co.
|
$59.34
|
$96.54B | 16.1 | 62 | Compare |
|
GSK
GSK plc American Depositary Shares (Each representing two Ordinary Shares)
|
$52.29
|
$91.59B | 14.1 | 54 | Compare |
|
BIIB
Biogen Inc. Common Stock
|
$209.03
|
$22.61B | 21.4 | 59 | Compare |
More AMGN Analysis
Data updated: Jul 14, 2026 | Industry: Drug Manufacturers - General (SIC 2836)
16 stocks in this industry